Genomatica raises $45m
Genomatica has raised $45m with new investors that include VantagePoint Venture Partners, Bright Capital and Waste Management. The new cash inflow will be used to complete the company's bio-butanediol (BDO) demonstration scale production planned for this year. Genomatica plans to have its first commercial scale plant start operating in late 2013.
Evonik buys medical bioplastic bizEvonik has acquired the biodegradable polymer portfolio Resomer from Boehringer Ingelheim. The degradable RESOMER® polymers are made from lactic acid and glycolic acid for use mostly in pharmaceutical and medical applications.